How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,653 results for

Antibiotic Food Interactions

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Antibiotic Food Interactions

Antibiotic Food Interactions Antibiotic Food Interactions Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Antibiotic Food Interactions (...) Antibiotic Food Interactions Aka: Antibiotic Food Interactions From Related Chapters II. Preparations: Antibiotics to take with food Food may reduce gastrointestinal upset Ethionamide ( ) Methenamine ( ) Niclosamide Praziquantel Pyrimethamine Quinacrine (with food and full glass of water) Quinine Rifabutin (may require supplement) Thiabendazole Food increases absorption or bioavailability ( ) ( ) ( ) Clofazimine (take with fatty meal) ( ) Mebendazole (Chew or crush tablet) (with food and a full glass

2018 FP Notebook

2. Drug-drug Interaction (DDI) With a P-gp Inhibitor, Organic Anion Transporting Polypeptide OATP-inhibitor, Food Effect

Drug-drug Interaction (DDI) With a P-gp Inhibitor, Organic Anion Transporting Polypeptide OATP-inhibitor, Food Effect Drug-drug Interaction (DDI) With a P-gp Inhibitor, Organic Anion Transporting Polypeptide OATP-inhibitor, Food Effect - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Drug-drug Interaction (DDI) With a P-gp Inhibitor, Organic Anion Transporting Polypeptide OATP-inhibitor, Food Effect The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03116893 Recruitment Status : Completed First Posted : April

2017 Clinical Trials

3. Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis

Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis - Full Text View - ClinicalTrials.gov Hide (...) glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects

2017 Clinical Trials

4. Is the use of chlorhexidine contributing to increased resistance to chlorhexidine and/or antibiotics?

Is the use of chlorhexidine contributing to increased resistance to chlorhexidine and/or antibiotics? 1 Is the use of chlorhexidine contributing to increased resistance to chlorhexidine and/or antibiotics? Technical Report Prepared for National Health and Medical Research Council (NHMRC) Submitted by University of South Australia Division of Health Sciences Submission date 24th April 2017 2 Contents Page 1. Review Team and Background…………………………..…………………………….….3 2. Methods (...) in ‘chlorhexidine resistance’ within different healthcare settings? 2. Does exposure (different dosages, duration of use, and stratification of exposure) to any form of chlorhexidine increase the incidence and/or prevalence of antibiotic-resistant strains of bacteria in any person within different healthcare settings? Table 1: PICOS overview Question 1 Population and setting Intervention Outcome Types of studies Qu 1 All patients (isolates) / participants (isolates) including children and adults in different

2018 National Health and Medical Research Council

5. HTA of C-reactive protein point-of-care testing to guide antibiotic prescribing

HTA of C-reactive protein point-of-care testing to guide antibiotic prescribing Health Technology Assessment (HTA) of CRP POCT Health Information and Quality Authority i Health Technology Assessment of C-reactive protein point-of-care testing to guide antibiotic prescribing for acute respiratory tract infections in primary care settings April 2019 Health Technology Assessment (HTA) of CRP POCT Health Information and Quality Authority ii Health Technology Assessment (HTA) of CRP POCT Health (...) a range of health services, in conjunction with the Department of Health and the HSE. Health Technology Assessment (HTA) of CRP POCT Health Information and Quality Authority iv Foreword Antimicrobial resistance occurs when bacteria adapt in response to the use of medicines. When bacteria become antibiotic resistant, infections become more difficult to manage and treat. Antimicrobial resistance is a significant threat to public health, and widely acknowledged to be associated with the excessive

2019 Health Information and Quality Authority

6. Probiotics can prevent bacterial diarrhoea in hospital patients receiving antibiotics

Probiotics can prevent bacterial diarrhoea in hospital patients receiving antibiotics Probiotics to prevent diarrhoea caused by C. difficile Discover Portal Discover Portal Probiotics can prevent bacterial diarrhoea in hospital patients receiving antibiotics Published on 1 May 2018 doi: Giving probiotics to people taking antibiotics reduces the chance of them developing diarrhoea caused by Clostridium difficile ( C. difficile ) bacteria by 60%. One case of Clostridium-associated diarrhoea (...) was prevented for every 42 people receiving probiotics. They appear to work best for patients at more than 5% risk of Clostridium infection. When antibiotics disturb healthy gut bacteria, Clostridium bacteria may multiply to toxic levels, causing diarrhoea and serious intestinal complications. Probiotics can be found in dietary supplements or yoghurts but are increasingly sold as capsules and contain live bacteria or yeast that may counteract these effects. This updated Cochrane review pooled 39 trials

2019 NIHR Dissemination Centre

7. The Rising Tide of Food Allergy

, probiotics, supplements that introduce potentially beneficial bacteria into the gut microbiome, are gaining traction as a potential therapy for allergic disease. Forsberg et al recently demonstrated improved immune regulation with lowered allergen responsiveness among infants who received pre- [ ]. Antibiotics can also significantly alter the composition of the gut microbiome and may thus play a large role in food allergy development, [ ]. An association between both maternal and child use of antibiotics (...) -year follow-up study. J Allergy Clin Immunol . 2003;112(6):1203-1207. Branum AM, Lukacs SL. Food allergy among children in the United States. Pediatrics . 2009;124(6):1549-1555. Hong X, Wang G, Liu X, Kumar R, Tsai HJ, Arguelles L, et al. Gene polymorphisms, breast-feeding, and development of food sensitization in early childhood. J Allergy Clin Immunol . 2011;128(2):374-381 e372. Liu X, Wang G, Hong X, Wang D, Tsai HJ, Zhang S, et al. Gene-vitamin D interactions on food sensitization

2016 Clinical Correlations

8. Adjuncts and alternatives in the time of antibiotic resistance and in‐feed antibiotic bans (PubMed)

Adjuncts and alternatives in the time of antibiotic resistance and in‐feed antibiotic bans 28643479 2018 09 27 2019 01 13 1751-7915 10 4 2017 07 Microbial biotechnology Microb Biotechnol Adjuncts and alternatives in the time of antibiotic resistance and in-feed antibiotic bans. 674-677 10.1111/1751-7915.12730 Brüssow Harald H Department of Gut Ecology, Host-Microbe Interaction Group, Nestlé Research Center, Lausanne, Switzerland. eng Editorial United States Microb Biotechnol 101316335 1751 (...) -7915 0 Anti-Bacterial Agents 0 Food Additives 0 Veterinary Drugs IM Animal Feed adverse effects analysis Animal Husbandry legislation & jurisprudence organization & administration Animals Anti-Bacterial Agents adverse effects analysis Drug Resistance, Microbial Food Additives analysis Humans Legislation, Veterinary organization & administration United States United States Food and Drug Administration Veterinary Drugs adverse effects analysis Veterinary Medicine organization & administration

Full Text available with Trip Pro

2017 Microbial biotechnology

9. Antibiotic Food Interactions

Antibiotic Food Interactions Antibiotic Food Interactions Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Antibiotic Food Interactions (...) Antibiotic Food Interactions Aka: Antibiotic Food Interactions From Related Chapters II. Preparations: Antibiotics to take with food Food may reduce gastrointestinal upset Ethionamide ( ) Methenamine ( ) Niclosamide Praziquantel Pyrimethamine Quinacrine (with food and full glass of water) Quinine Rifabutin (may require supplement) Thiabendazole Food increases absorption or bioavailability ( ) ( ) ( ) Clofazimine (take with fatty meal) ( ) Mebendazole (Chew or crush tablet) (with food and a full glass

2015 FP Notebook

10. Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment

Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment | Circulation: Cardiovascular Genetics Search Hello Guest! Login to your account Email Password Keep me logged in Search February 2019 January 2019 This site uses cookies. By continuing to browse this site you (...) are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment A Scientific Statement From the American Heart Association , PhD, FAHA, Chair , PhD, FAHA , MD, FAHA , PhD , PhD, RD, FAHA , PhD , ScD, ACE, FAHA , and MD, FAHA PhD, Co-Chairon behalf of the American Heart Association Council on Functional Genomics and Translational Biology

Full Text available with Trip Pro

2016 American Heart Association

11. Antibiotic prophylaxis for GI endoscopy

Antibiotic prophylaxis for GI endoscopy GUIDELINE Antibiotic prophylaxis for GI endoscopy Thisisoneofaseriesofstatementsdiscussingtheuseof GI endoscopy in common clinical situations. The Stan- dards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this docu- ment, and it updates a previously issued document on this topic. 1 In preparing this guideline, MEDLINE and PubMed databases were used to search for publications between January 1975 and December (...) in remote tissues (ie, infec- tive endocarditis [IE]). Endoscopy also may result in local infections in which a typically sterile space or tissue is breached and contaminated by an endoscopic accessory or by contrast material injection. This document is an up- date of the prior ASGE document on antibiotic prophylaxis for GI endoscopy, 1 discusses infectious adverse events related to endoscopy, and provides recommendations for periprocedural antibiotic therapy. BACTEREMIA ASSOCIATED WITH ENDOSCOPIC

2015 American Society for Gastrointestinal Endoscopy

12. A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies

A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record (...) Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal

2014 Clinical Trials

13. How Political Cultures Produce Different Antibiotic Policies in Agriculture: A Historical Comparative Case Study between the United Kingdom and Sweden (PubMed)

risks of agricultural antibiotic use; and Sweden, the first country to produce legislation on the growth promotor use of antibiotics in food animals. Sheila Jasanoff's concepts of 'co-production' and 'political cultures' have been used to explore how both countries used different styles of scientific reasoning and justification of the risks of agricultural antibiotic use. It will be argued that national dynamics between policy, science and public knowledges co-produced different risk classifications (...) and patterns of agricultural antibiotic use between both countries. UK's political culture used 'expert committees' to remove the issue from public debate and to inform agricultural antibiotic policies. In contrast, the Swedish 'consensus-oriented' political culture made concerns related to agricultural antibiotic use into a cooperative debate that included multiple discourses. Understanding how national policies, science and public knowledges interact with the risks related to agricultural antibiotic use

Full Text available with Trip Pro

2018 Sociologia Ruralis

14. The influence of antibiotics and dietary components on gut microbiota (PubMed)

The influence of antibiotics and dietary components on gut microbiota The gut microbiota acts as a real organ. It exerts important metabolic functions, and regulates the inflammatory response by stimulating the immune system. Gut microbial imbalance (dysbiosis) has been linked to important human diseases and inflammation-related disorders. The symbiotic interactions between resident microorganisms and the gastrointestinal tract significantly contribute to maintaining gut homeostasis (...) . The present review summarizes our knowledge regarding the impact of different antibiotics causing such long-term consequences as decreased microbial diversity, modulation of the Bacteroidetes/Firmicutes ratio, Clostridium difficile overgrowth, and increased expansion of the opportunistic pathogens Salmonella typhimurium, Escherichia spp., and Klebsiella spp. Also, food additives, such as emulsifiers and artificial sweeteners, which are meant to reduce the risk of obesity and diabetes, may actually

Full Text available with Trip Pro

2018 PrzeglaÌœd gastroenterologiczny

15. Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease (MAC2v3) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03672630

2018 Clinical Trials

16. Microbiota and Food Allergy. (PubMed)

Microbiota and Food Allergy. Emerging evidence suggests that the increasing prevalence of food allergies is associated with compositional and functional changes in our gut microbiota. Microbiota-host interactions play a key role in regulating the immune system. Development of a healthy gut microbiota and immune system occurs early in life and is largely shaped by exposure to maternal microbes through vaginal/natural delivery and breast milk, whereas use of antibiotics can disrupt gut (...) treatment for food allergies, probiotics have gained widespread attention in recent years. Reintroducing certain commensal microbes, such as Clostridia, both in animal models and clinical trials led to the prevention or resolution of allergic symptoms. This review highlights recent progress in our understanding of the gut microbiota's role in food allergy. However, mechanistic details underlying the anti-allergic effects of probiotics and the interaction between the gut microbiota and the immune system

2018 Clinical Reviews in Allergy & Immunology

17. The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH

, 1,25 (OH)D; reduced PTH, reduced 24,25(OH)2D, and suppresses 24,1,25 (OH)2D, normal serum creatinine, AST, and ALT with or without biallelic inactivating mutations of CYP24A1 mutations in newly published genes which are shown during the course of the study to cause an inappropriate increase in 1,25 (OH)2D Exclusion Criteria: Allergy to rifampin or related medications Pregnancy or breastfeeding Significant cardiac, hepatic, or endocrine comorbidities Taking any medications/foods known to interact (...) The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2017 Clinical Trials

18. Molecular State of the Membrane-Active Antibiotic Daptomycin (PubMed)

Molecular State of the Membrane-Active Antibiotic Daptomycin Membrane-active antibiotics are potential alternatives to the resistance-prone conventional antibiotics. Daptomycin, a cyclic lipopeptide, is the only membrane-active antibiotic approved by the U.S. Food and Drug Administration so far. The drug interacts with the cytoplasmic membranes of Gram-positive pathogens, causing membrane permeabilization to ions and cell death. The antibiotic activity is calcium-ion dependent and correlates (...) with the target membrane's content of phosphatidylglycerol (PG). For such a complex reaction with membranes, it has been difficult to uncover the molecular process that underlies its antibacterial activity. The role of the cofactor, calcium ions, has been confusing. Many have proposed that calcium ions binding to daptomycin is a precondition for membrane interaction. Here, we report our findings on the molecular state of daptomycin before and after its membrane-binding reaction, particularly at therapeutic

Full Text available with Trip Pro

2017 Biophysical journal

19. Food Effect Study of ModraDoc006 in Combination With Ritonavir

Food Effect Study of ModraDoc006 in Combination With Ritonavir Food Effect Study of ModraDoc006 in Combination With Ritonavir - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Food Effect Study of ModraDoc006 (...) Party): Modra Pharmaceuticals Study Details Study Description Go to Brief Summary: This study aims to evaluate the effect of food on the pharmacokinetics of ModraDoc006 in combination with ritonavir, in an open-label, cross-over design. Patients will be randomized into two treatment groups receiving ModraDoc006/r week 1 under fasting and week 2 under fed condition, or vice versa. Condition or disease Intervention/treatment Phase Solid Tumor, Adult Drug: ModraDoc006/r Phase 1 Detailed Description

2017 Clinical Trials

20. Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective (PubMed)

antimicrobial spectra and/or result in a reduction in the concentration of an antibiotic required for effective treatments to the extent that potentially toxic or adverse side effects can be reduced or eliminated. Here, we review studies in which bacteriocins were found to be effective in combination with other antimicrobials, with a view to targeting clinical and/or food-borne pathogens. Furthermore, we discuss some of the bottlenecks which are currently hindering the development of bacteriocins as viable (...) Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective The continuing emergence of multi-drug resistant pathogens has sparked an interest in seeking alternative therapeutic options. Antimicrobial combinatorial therapy is one such avenue. A number of studies have been conducted, involving combinations of bacteriocins with other antimicrobials, to circumvent the development of antimicrobial resistance and/or increase antimicrobial potency. Such bacteriocin-antimicrobial combinations

Full Text available with Trip Pro

2017 Frontiers in microbiology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>